Divalent SARS-CoV-2 fusion vaccine found to be effective in mice - News-Medical.Net

Researchers bioengineered a divalent fusion vaccine by combining the immunogenic region of the nucleocapsid protein and the receptor-binding domain of the spike protein of SARS-CoV-2.

In a recent study published in Vaccines, researchers bioengineered a divalent fusion vaccine by combining the immunogenic region of the nucleocapsid (N) protein and receptor-binding domain (RBD) of t… [+5420 chars]

full article...